1
|
|
Fluoxetine Shows Promise in Multiple
Sclerosis CME
|
2
|
|
Provigil Linked to Risk for
Serious Skin Rash, Psychiatric
Symptoms
|
3
|
|
Minocycline May Improve
Stroke Outcomes Out to 24 Hours
|
4
|
|
Diagnosis and Management of
Parkinson's Disease CME/CE
|
5
|
|
Pergolide Withdrawn From US
Market
|
6
|
|
WSJ Reports on Possible
Interaction Between Statin Use and Development of
ALS
|
7
|
|
The
Current and Emerging Landscape of MS Treatment CME/CE
|
8
|
|
DNA
Vaccine Alters Natural Course of Multiple Sclerosis CME
|
9
|
|
"Whispering" Strokes Impair Quality
of Life CME
|
10
|
|
Stroke Prevention: New Results From
Major Clinical Trials CME
|